Abstract
Background
The internet, especially YouTube, has become a prominent source of health information. However, the quality and accuracy of medical content on YouTube vary, posing concerns about misinformation. This study focuses on providing reliable information about hereditary breast cancer on YouTube, given its importance for decision-making among patients and families. The study examines the quality and accessibility of such content in Japanese, where limited research has been conducted.
Methods
A nonprofit organization called BC Tube was established in May 2020 to create informative videos about breast cancer. The study analyzed 85 YouTube videos selected using the Japanese keywords “hereditary breast cancer” and “HBOC”, categorized into six groups based on the source of upload: BC Tube, hospitals/governments, individual physicians, public-interest organizations/companies, breast cancer survivors, and others. The videos were evaluated based on various factors, including content length, view counts, likes, comments, and the presence of advertisements. The content was evaluated using the PEMAT and DISCERN quality criteria.
Results
BC Tube created high-quality videos with high scores on PEMAT understandability, significantly outperforming other sources. Videos from public-interest organizations/companies received the most views and likes, despite their lower quality. Videos from medical institutions and governments were of superior quality but attracted less attention.
Conclusions
Our study emphasizes the importance of promoting accessible, easy-to-understand, and widely recognized medical information online. The popularity of videos does not always correspond to their quality, emphasizing the importance of quality evaluation. BC Tube provides a peer-reviewed platform to disseminate high-quality health information. We need to develop high-quality online health information and encourage the promotion of evidence-based information on YouTube.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
With advanced information technology, the internet has become an important and easily accessible source of health information for patients [1]. Online video-sharing platforms are popular due to lifestyle changes resulting from the increased use of smartphones, tablets, social media, and cloud computing [2]. YouTube is the most widely used online video-sharing platform (www.youtube.com; YouTube LLC, San Bruno, CA) [3, 4]. The impact of YouTube on the dissemination of health information, including information about breast cancer, to the general public is continuously being studied [5,6,7]. Video can assist patients with low literacy skills and aid in making complex decisions by providing visual information. Videos may be more appealing to younger patients accustomed to multimedia as a primary source of information [8]. Medical information is fundamental to decision-making among cancer patients and families [9]. Unfortunately, a significant amount of internet medical resources is unregulated and may contain inaccurate or misleading information [10]. The dissemination of biased and misinformative medical content is a major societal issue with serious implications for decision-making and outcomes [11]. The quality of health information depends not only on accuracy and reliability but also on website interactivity and usability, including vested commercial or financial interests of the authors or sponsors and characteristics of the authors and language [12]. Quality, easy-to-understand, and accessible information is needed.
Hereditary breast cancer accounts for 5–10% of all breast cancers [13], and hereditary breast and ovarian cancer (HBOC) is the most common type [14]. BRCA1/2 genetic testing and medical management, including prophylactic surgery and surveillance of HBOC patients, have been covered by Japanese national health insurance since April 2020, leading to increased BRCA1/2 genetic testing and prophylactic interventions [15, 16]. The clinical benefits of genetic testing and therapeutic and preventive interventions can be optimized by providing appropriate information on hereditary breast cancer to patients and their families. An online video-sharing platform is practical for providing hereditary breast cancer information because information can be delivered to a wide audience, including patients, relatives, and people who have not yet developed cancer, and videos can be viewed repeatedly. However, few studies have examined the hereditary breast cancer information available on YouTube [5], and no studies have focused on the distribution of YouTube videos in Japanese.
In May 2020, we established an editorial board for a nonprofit general incorporated association called Breast Cancer Tube (BC Tube). We began providing animated, easy-to-understand videos with reliable medical information about breasts and breast cancer via the YouTube channel “Breast Cancer Encyclopedia [BC Tube Editors].” The purpose of the videos was to promote public breast awareness and create an internet learning environment where patients and families can access quality internet resources for breast cancer. The advantage of online video-sharing platforms is the ability to provide information on hereditary breast cancer to a wide audience, including patients, families, distant relatives who cannot visit the doctor, and people who do not have the opportunity to visit a medical institution. Moreover, videos can be viewed repeatedly and free of charge. Multimedia delivery of information using videos, animations, infographics, text, and audio can potentially enhance comprehension [17, 18]. However, the usefulness of our content compared to other videos was unclear.
The aim of this study was to present our online video production activities and assess the quality, content, and readability of current health information about hereditary breast cancer on YouTube. Using the following search terms, “hereditary breast cancer (kanji and hiragana notation)” and “HBOC,” we evaluated the first 100 YouTube videos and conducted a systematic evaluation of the quality of breast cancer information available on YouTube using validated assessment instruments, including the Patient Education Materials Assessment Tool (PEMAT) [19] and the DISCERN quality criteria for consumer health information [20]. Furthermore, we compared the quality of BC Tube content with other online videos.
Materials and methods
Nonprofit general incorporated association called BC Tube
We established a nonprofit general incorporated association called BC Tube in May 2020. Up to March 31st, 2023, 52 videos were created, including videos on breast health education (symptoms, breast awareness, and epidemiology), screening, diagnosis, treatment of early-stage breast cancer, metastatic/recurrent breast cancer, side effects of treatment, and hereditary breast cancer. This content was viewed over 1,200,000 times over 59,000 h per year from July 2020 to March 2023. Five of our videos were about hereditary breast cancer.
Searching and selection of YouTube videos for study inclusion
To examine the current information about hereditary breast cancer and HBOC on YouTube, we performed searches using the keywords “hereditary breast cancer (“cancer” written in kanji)” and “hereditary breast cancer (“cancer” in Hiragana), and “HBOC” in Japanese on July 7th, 2022 and selected the top 100 YouTube videos for each search term. The searches were conducted after cleaning the search history and without logging into any account. We used relevance-based ranking to sort the results, and the top 100 videos were assessed. The number of videos analyzed was based on previous studies that analyzed the first 50–170 videos [21,22,23,24].
Two non-medical investigators independently screened the videos. The independent investigators had no conflicts of interest with BC Tube or any other YouTube content creation organizations. The review included Japanese language videos and English videos with Japanese subtitles. We excluded duplicate videos and content not containing information about hereditary breast cancer.
Video classification
To compare the distinctions among sources and assess the contrasts between BC Tube and the others, videos were classified by the source of upload into 6 groups, including BC Tube, hospitals/governments, individual physicians, public-interest organizations/companies, breast cancer survivors, and others. The hospital/governments group included videos by the national cancer institute, prefectures, universities, and hospitals/clinics (single facility). The public-interest organizations/companies included broadcasting stations, newspapers, nonprofit organizations, and profit organizations. The “others” group included three recorded deliveries of other distributors’ videos and three videos by unknown sources. All three recorded deliveries were from public-interest organizations/companies.
Viewing status and quality of content analyses
The source/providers of content, the time since upload, the content length, the view counts, the number of comments, the number of likes, and advertisement displays were recorded. The quality of breast cancer information was evaluated systematically with a range of metrics, including content accuracy, readability, and accountability, using validated assessment instruments, including the PEMAT [25] and the DISCERN quality criteria for consumer health information [26], as shown in Table 2. PEMAT is a systematic method to evaluate the understandability and actionability of patient education materials. Separate tools are available for print and audiovisual materials. We used the PEMAT instrument for audiovisual materials. In the DISCERN score, Questions 1–8 focus on the reliability of the contents to judge whether it can be trusted as a source of information about treatment choices. Questions 9–15 focus on specific details about treatment choices. Question 16 shows the overall quality rating at the end of the instrument. Two independent investigators evaluated the content independently. We compared the quality of the content from the six sources.
Statistical analysis
Statistical analysis was performed using R software and GraphPad Prism 8 software. One-way analysis of variance for multiple comparison tests. Data are reported as the averages with standard errors of the average for each group. Results were considered significant at p values below 0.05.
Results
The process of creating videos by the BC Tube
We created online video content on breast cancer (Fig. 1). Content development was discussed by multiple breast medical oncologists and surgeons. First, the key messages and target audience were discussed among the BC Tube editorial board members. Then, the main writer and the second-in-command staff were selected. The BC Tube editorial board reviewed the draft. If the BC Tube editorial board members agreed that the content was well-produced, the content was reviewed by an external peer review group of independent breast medical oncologists and surgeons to ensure scientific validity. The narration text was also reviewed. After external peer review, the revised content was reviewed by all BC Tube editorial board members again. The content was converted to a video format with narration and animation. The narration text was inserted at the bottom of the video. Videos were no more than 10 min to promote sustained concentration while viewing the YouTube viewing screen. The video was reviewed by the BC Tube Support Group to ensure readability and ensure that no offensive expressions were included. The BC Tube Support Group is a general citizen group consisting of 110 volunteers who were selected through open recruitment, including women and men who have not been diagnosed with breast cancer, breast cancer patients, breast cancer survivors, and medical staff other than breast medical oncologists/surgeons.
Finally, the videos were uploaded to the YouTube channel “Breast Cancer Encyclopedia [BC Tube Editors]” (https://www.youtube.com/@-BCTube), and the content was spread through social media, including the BC Tube Website, Twitter, Facebook, and Instagram. A link to a questionnaire form was placed in the summary section of the YouTube video to obtain opinions and feedback from viewers.
Content characteristics
The strategy to select the videos included in the analysis is outlined in the CONSORT diagram (Fig. 2). Ninety-nine duplicated videos were excluded, and 107 videos without information about hereditary breast cancer were excluded, including content with general information about breast cancer treatment, introduction to statistical analysis using genetic breast cancer data, and content introducing cars with HBOC in the name. Nine videos in English without any Japanese information were excluded. Thus, 85 videos were eligible for this study.
A majority of the videos (43 videos, 50.6%) were provided by public-interest organizations/companies, followed by hospitals/governments (18 videos, 21.2%), individual physicians (7 videos, 8.2%), breast cancer survivors (6 videos, 7.1%), and others (6 videos, 7.1%) (Fig. 3A, Table 1). Five videos about genetics and breast cancer produced by the BC Tube were included in the top 100 for “hereditary breast cancer (in hiragana)”; 4 videos were included in the top 100 for “hereditary breast cancer (in kanji),” and 2 videos were included in the top 100 for “HBOC.”
The average length of the BC Tube (7.1 ± 2.3 min), individual physician (8.9 ± 3.0 min), and breast cancer survivor (9.0 ± 4.7 min) videos tended to be shorter compared with the length of the hospital/government (26.9 ± 43.3), public-interest organization/company (23.3 ± 27.0 min), and “other” (24.0 ± 11.7 min) videos. However, differences between groups were not significant (Fig. 3B, Table 1). The time since the upload of videos on YouTube was significantly longer for videos posted by public-interest organizations/companies compared with videos posted by hospitals/governments (p = 0.017) and breast cancer survivors (p < 0.01) (Fig. 3C, Table 1). The time since upload of videos from the “others” group was longer than the times for other groups (Fig. 3C, Table 1). These results suggest that public-interest organizations and companies focused earlier on providing information on hereditary breast cancer via YouTube than other sources. The same trend was evident in the “others” group, which included three recorded videos from public-interest organizations. Most videos created by hospitals and governments and breast cancer survivors were sent out around 2020, when health insurance coverage for BRCA1/2 genetic testing and HBOC treatment began in Japan.
We used YouTube Analytics to check the viewing status of BC Tube videos. The view counts per day decreased after the videos were posted. Therefore, we compared the total view counts instead of the number of views per unit of time. Public-interest organizations/companies exhibited the highest number of views (26,686.8 ± 156,763.4), followed by BC Tube (5614.8 ± 1690.2) (Fig. 3D, Table 1). Hospital/ governments (1115.7 ± 1307.7), breast cancer survivors (1343.7 ± 1572.3), and the “others” group (1213.0 ± 1530.2) showed similar view counts whereas individual physicians (540.5 ± 395.6) showed the lowest view counts although the differences were not significant (Fig. 3D, Table 1). Three videos from hospitals/governments and 10 videos from public-interest organizations/companies disabled the view counters on YouTube. Public-interest organizations/companies (65.0 ± 280.1) had the highest number of “likes,” followed by BC Tube (56.2 ± 6.9) and breast cancer survivors (34.2 ± 44.8) (Fig. 3E, Table 1).
All BC Tube videos turned off the comments to avoid personal consultations but employed a survey form in the summary section to receive feedback. Five BC Tube videos, 8 videos from hospitals/governments, and 15 videos from public-interest organizations/companies disabled comments. Excluding these videos, breast cancer survivors had the highest number of comments (5.7 ± 8.5) followed by public-interest organizations/companies (3.8 ± 17.0); however, the differences were not significant (Fig. 3F, Table 1). The viewers may find assessing the impartiality of content creators who display advertisements on YouTube difficult. To address this issue, the BC Tube does not show advertisements. Aside from the BC Tube, no significant differences in the number of videos with advertisements among the four groups were detected (Fig. 3G, Table 1).
Quality analysis of YouTube content
To elucidate the quality of hereditary breast cancer information content, we applied two validated assessment instruments: PEMAT and DISCERN quality criteria. All 5 videos made by the BC Tube had perfect scores for PEMAT understandability scores; the PEMAT scores for BC Tube videos were significantly higher than the scores of the other groups (Fig. 4A). The videos from breast cancer survivors had significantly lower PEMAT understandability scores compared with the other groups (Fig. 4A). Videos from BC Tube, hospitals/governments, individual physician, public-interest organizations/companies and “others” had significantly higher PEMAT actionability scores compared with breast cancer survivors (p < 0.01 in all) (Fig. 4B). Videos made by the BC Tube had higher PEMAT actionability scores than public-interest organizations/companies (p < 0.05) (Fig. 4B).
Question 16 of the DISCERN score is an overall rating of the content quality. The BC Tube videos had higher overall quality ratings compared with all other groups (Fig. 4C). The breast cancer survivor videos had significantly lower DISCERN score compared with the other groups (Fig. 4C). Collectively, these results indicate that videos from BC Tube, hospitals, and governments were high quality, leading viewers to take action. Videos sent by individual contributors, such as breast cancer survivors, were generally of lower quality based on the qualitative scale (Tables 2 and 3).
Discussion
This is the first report introducing a novel breast cancer information-sharing system. The online video platform was peer-reviewed to ensure reliability and was scrutinized by the general public to ensure patient and public involvement. We summarized the quality and viewing status of hereditary breast cancer information currently available on YouTube.
To our knowledge, no reports have focused on the practice of providing medical information on hereditary breast cancer using online video-sharing platforms like YouTube. Several reports analyzed the quality of breast cancer information on YouTube, suggesting the growing awareness of the impact of poor-quality online health-related content [27,28,29]. Two overseas randomized controlled trials, MAGENTA (Clinicaltrials.gov identifier: NCT02993068) [30] and ProGen (ClinicalTrials.gov identifier: NCT03328091) [31], compared the effectiveness of online genetic education with different counseling approaches. In Japan, one recent report showed the efficacy of smartphone psychotherapy to reduce the fear of cancer recurrence among breast cancer survivors in decentralized randomized controlled clinical trials [32].
Providing medical information using the BC Tube strategy has several advantages. First, we adopted a collaborative format between physicians and citizens and recruited a wide range of volunteers, consisting mainly of non-medical professionals. This collaborative format promotes the delivery of easy-to-understand medical information that reaches a wider audience. Recruiting diverse participants to science fosters fairness and impartiality, and diverse cultural perspectives contribute to better outcomes [33]. Second, the peer review system ensures that the information is evidence-based. Peer review improves the quality and accuracy of scientific research [34] and is an effective and appropriate method. Third, we used the most common online video-sharing platform, YouTube. Viewers can watch the information repeatedly anytime and anywhere. Furthermore, people can share the information with their families, blood relatives, and partners.
About half of the YouTube videos analyzed in this study were from public-interest organizations/companies and these videos obtained more view counts. Public-interest organizations/companies began distributing videos about hereditary breast cancer on YouTube much earlier than other organizations, while most videos from medical institutions and governments were more recent, especially videos about genetic testing and HBOC treatment, which started to be covered by health insurance. Moreover, videos from public-interest organizations/companies and breast cancer survivors acquired more likes and comments, suggesting that videos from non-medical facilities and people received more attention from viewers. On the other hand, the quality of videos from medical institutions and the government was superior. Thus, the popularity did not correspond to the quality of video content. To ensure that high-quality videos are viewed by a wider audience, the posting organization needs to devise ways to improve the promotion and presentation of the videos.
The length of BC Tube videos is limited to less than 10 min to encourage viewers to focus and not move on to other videos. The quality of BC Tube’s content is high, and the likes and view counts show that BC Tube is gaining attention, but needs more recognition. Currently, the videos are played in waiting rooms at some medical facilities and breast clinics to provide breast health information to examinees and patients. In addition, the BC Tube platform is sometimes used for the education of healthcare workers, medical students, and residents at teaching hospitals.
Social media is becoming more diverse, and citizens obtain information from various media platforms, such as Twitter, Instagram, and Facebook, based on their generation and lifestyle. Evaluating information about dissemination methods and modifying the methods in response to changes in citizens and current trends is necessary. In addition, devising a strategy to provide medical information to online-independent citizens is also necessary.
A limitation for this study is that the results of this study depend on YouTube’s search algorithm. On YouTube, efforts are being made to identify information sources based on principles and definitions created by the World Health Organization (WHO) and the National Academy of Medicine (NAM), aiming to provide content originating from reliable sources [35]. In Japan, the YouTube Health team is also working on initiatives to make it easier to identify high-quality information sources [36]. While the findings of this study may not be universal due to the impact of fluctuations in YouTube’s search algorithm, they are important for disseminating higher-quality video information to the public.
In conclusion, we introduced a novel system for providing reliable information on breast cancer using the online video-sharing platform, YouTube, in collaboration with physicians and citizens. Videos distributed by hospitals and governments were of higher quality but need more views or attention. The promotion of online medical information that is reliable, easy-to-understand, and widely recognized is crucial.
Data availability
The datasets generated and analyzed in this study are available from the corresponding author upon reasonable request.
References
Wimble M. Understanding health and health-related behavior of users of Internet health information. Telemed J E Health. 2016;22(10):809–15. https://doi.org/10.1089/tmj.2015.0267.
Purcell K. The state of online video. Washington DC. 2010. https://www.pewresearch.org/internet/2010/06/03/the-state-of-online-video/. Accessed 26 May 2023.
Routley N. Ranking the top 100 Websites in the world. 2019. https://www.visualcapitalist.com/ranking-the-top-100-websites-in-the-world/. Accessed 26 May 2023.
Anderson APM. Share of U.S. adults using social media, including Facebook, is mostly unchanged since 2018. 2019. https://www.pewresearch.org/fact-tank/2019/04/10/share-of-u-s-adults-using-social-media-including-facebook-is-mostly-unchanged-since-2018/. Accessed 26 May 2023.
Laforet PE, Yalamanchili B, Hillyer GC, et al. YouTube as an information source on BRCA mutations: implications for patients and professionals. J Community Genet. 2022;13(2):257–62. https://doi.org/10.1007/s12687-022-00576-1.
Basch CH, Menafro A, Mongiovi J, et al. A content analysis of YouTube™ videos related to prostate cancer. Am J Mens Health. 2017;11(1):154–7. https://doi.org/10.1177/1557988316671459.
Ayoub G, Chalhoub E, Sleilaty G, et al. YouTube as a source of information on breast cancer in the Arab world. Support Care Cancer. 2021;29(12):8009–17. https://doi.org/10.1007/s00520-021-06403-6.
Winston K, Grendarova P, Rabi D. Video-based patient decision aids: a scoping review. Patient Educ Couns Patient ed. 2018;101(4):558–78. https://doi.org/10.1016/j.pec.2017.10.009.
Beers E, Lee Nilsen M, Johnson JT. The role of patients: shared decision-making. Otolaryngol Clin North Am. 2017;50(4):689–708. https://doi.org/10.1016/j.otc.2017.03.006.
Zhang Y, Sun Y, Xie B. Quality of health information for consumers on the web: a systematic review of indicators, criteria, tools, and evaluation results. J Assoc Inf Sci Technol. 2015;66(10):2071–84. https://doi.org/10.1002/asi.23311.
Castleton K, Fong T, Wang-Gillam A, et al. A survey of internet utilization among patients with cancer. Support Care Cancer. 2011;19(8):1183–90. https://doi.org/10.1007/s00520-010-0935-5.
Sbaffi L, Rowley J. Trust and credibility in web-based health information: a review and agenda for future research. J Med Internet Res. 2017;19(6): e218. https://doi.org/10.2196/jmir.7579.
Campeau PM, Foulkes WD, Tischkowitz MD. Hereditary breast cancer: new genetic developments, new therapeutic avenues. Hum Genet. 2008;124(1):31–42. https://doi.org/10.1007/s00439-008-0529-1.
Kast K, Rhiem K, Wappenschmidt B, et al. Prevalence of BRCA1/2 germline mutations in 21 401 families with breast and ovarian cancer. J Med Genet. 2016;53(7):465–71. https://doi.org/10.1136/jmedgenet-2015-103672.
Hayashi S, Kubo M, Kaneshiro K, et al. Genetic medicine is accelerating in Japan. Breast Cancer. 2022;29(4):659–65. https://doi.org/10.1007/s12282-022-01342-4.
Nomura H, Ikki A, Fusegi A, et al. Clinical and pathological outcomes of risk-reducing salpingo-oophorectomy for Japanese women with hereditary breast and ovarian cancer. Int J Clin Oncol. 2021;26(12):2331–7. https://doi.org/10.1007/s10147-021-02020-9.
Palmer BW, Lanouette NM, Jeste DV. Effectiveness of multimedia aids to enhance comprehension of research consent information: a systematic review. IRB. 2012;34(6):1–15.
Hopper KD, Zajdel M, Hulse SF, et al. Interactive method of informing patients of the risks of intravenous contrast media. Radiology. 1994;192(1):67–71. https://doi.org/10.1148/radiology.192.1.8208968.
Shoemaker SJ, Wolf MS, Brach C. Development of the patient education materials assessment tool (PEMAT): a new measure of understandability and actionability for print and audiovisual patient information. Patient Educ Couns Patient ed. 2014;96(3):395–403. https://doi.org/10.1016/j.pec.2014.05.027.
Charnock D, Shepperd S, Needham G, et al. DISCERN: an instrument for judging the quality of written consumer health information on treatment choices. J Epidemiol Community Health. 1999;53(2):105–11. https://doi.org/10.1136/jech.53.2.105.
Pan P, Yu C, Li T, et al. Xigua video as a source of information on breast cancer: content analysis. J Med Internet Res. 2020;22(9): e19668. https://doi.org/10.2196/19668.
Yurdaisik I. Analysis of the most viewed first 50 videos on YouTube about breast cancer. BioMed Res Int. 2020;2020:2750148. https://doi.org/10.1155/2020/2750148.
Güloğlu S, Özdemir Y, Basim P, et al. YouTube English videos as a source of information on arm and shoulder exercise after breast cancer surgery. Eur J Cancer Care (Engl). 2022;31(6): e13685. https://doi.org/10.1111/ecc.13685.
Li Y, Zhou X, Zhou Y, et al. Evaluation of the quality and readability of online information about breast cancer in China. Patient Educ Couns Patient ed. 2021;104(4):858–64. https://doi.org/10.1016/j.pec.2020.09.012.
Brach SJSMSWC. The Patient Education Materials Assessment Tool (PEMAT) and User’s Guide. 2013. https://www.ahrq.gov/health-literacy/patient-education/pemat.html. Accessed 26 May 2023.
Project TDotI. DISCERN Online, Quality Criteria for Consumer Health Information. 1999. http://www.discern.org.uk. Accessed 26 May 2023.
Basch CH, MacLean SA, Garcia P, et al. Readability of online breast cancer information. Breast J. 2019;25(3):562–3. https://doi.org/10.1111/tbj.13276.
Brar J, Khalid A, Ferdous M, et al. Breast cancer screening literacy information on online platforms: a content analysis of YouTube videos. Breast Dis. 2022;41(1):81–7. https://doi.org/10.3233/BD-201028.
Arif N, Ghezzi P. Quality of online information on breast cancer treatment options. Breast. 2018;37:6–12. https://doi.org/10.1016/j.breast.2017.10.004.
Rayes N, Bowen DJ, Coffin T, et al. Magenta (Making Genetic testing accessible): a prospective randomized controlled trial comparing online genetic education and telephone genetic counseling for hereditary cancer genetic testing. BMC Cancer. 2019;19(1):648. https://doi.org/10.1186/s12885-019-5868-x.
Berchuck JE, Boiarsky D, Silver R, et al. Addition of germline testing to tumor-only sequencing improves detection of pathogenic germline variants in men with advanced prostate cancer. JCO Precis Oncol. 2022;6: e2200329. https://doi.org/10.1200/PO.22.00329.
Akechi T, Yamaguchi T, Uchida M, et al. Smartphone psychotherapy reduces fear of cancer recurrence among breast cancer survivors: a fully decentralized randomized controlled clinical trial (J-SUPPORT 1703 study). J Clin Oncol. 2022. https://doi.org/10.1200/jco.22.00699.
National Academies of Sciences E, Medicine, Division of B, et al. Learning through citizen science: Enhancing opportunities by design. In: Dibner KA, Pandya R editors. National Academies Press (US) copyright 2018 by National Academy of Sciences. All rights reserved: Washington (DC); 2018.
Twaij H, Oussedik S, Hoffmeyer P. Peer review. Bone Joint J. 2014;96-B(4):436–41. https://doi.org/10.1302/0301-620X.96B4.33041.
National academy of medicine. Identifying credible sources of health information on digital platforms. 2021. https://nam.edu/programs/principles-for-defining-and-verifying-the-authority-of-online-providers-of-health-information/. Accessed 26 Sep 2023.
YouTube Japan Official Blog. New ways to find reliable medical/health information. 2022. https://youtube-jp.googleblog.com/2022/03/new-health-feature.html. Accessed 26 Sep 2023.
Acknowledgements
The authors would like to thank: Kanako Nishiyama, Tomoko Shibayama, Kazuki Nozawa and Megumi Sano for their editorial help. We thank those authors whom we were not able to cite because of limited space.
Funding
This research was funded by Project Mirai Cancer Research Grants from Relay for Life, Japan Cancer Society (Tokyo, Japan) to Asumi Iesato.
Author information
Authors and Affiliations
Contributions
Conception and design: AI; data analysis: AI, AF; writing—original draft preparation: AI; writing—review and editing; AF, RT, MT, MI, CK, NY; funding acquisition: AI.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
This article is published under an open access license. Please check the 'Copyright Information' section either on this page or in the PDF for details of this license and what re-use is permitted. If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team.
About this article
Cite this article
Iesato, A., Fushimi, A., Tahara, R. et al. A novel system to provide information via online YouTube videos and an evaluation of current online information about hereditary breast cancer. Breast Cancer 31, 63–74 (2024). https://doi.org/10.1007/s12282-023-01512-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12282-023-01512-y